Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Abandoned drugs
Estradiol diundecylate/hydroxyprogesterone heptanoate/testosterone cyclohexylpropionate
Другие языки:

    Estradiol diundecylate/hydroxyprogesterone heptanoate/testosterone cyclohexylpropionate

    Подписчиков: 0, рейтинг: 0
    EDU/OHPH/TCHP
    Combination of
    Estradiol diundecylate Estrogen
    Hydroxyprogesterone heptanoate Progestogen
    Testosterone cyclohexylpropionate Androgen; Anabolic steroid
    Clinical data
    Trade names Trioestrine Retard
    Other names EDU/OHPH/TCHP
    Routes of
    administration    		 Intramuscular injection

    Estradiol diundecylate/hydroxyprogesterone heptanoate/testosterone cyclohexylpropionate (EDU/OHPH/TCHP), sold under the brand name Trioestrine Retard, is an injectable combination medication of estradiol diundecylate (EDU), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone cyclohexylpropionate (TCHP), an androgen/anabolic steroid. It contained 2.25 mg EDU, 100 mg OHPH, and 67.5 mg TCHP in oil solution, was provided as ampoules, and was administered by intramuscular injection. The medication was manufactured by Roussel and Théramex and was marketed by 1953. It is no longer available.

    See also



    Новое сообщение